Electra Therapeutics ($ETRA) Insider Trading & Smart Money Activity

Electra Therapeutics, Inc. · Latest filing Sep 21, 2026

Electra Therapeutics, Inc. ($ETRA) has 2 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($40M) and no insider sold, net +$40M.

Insider buyers (12 mo)

2

Insider sellers (12 mo)

0

Net insider $ (12 mo)

+$40M

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

ETRA insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	2 · $40M	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ETRA insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Sep 21, 2026	Insider	Orbimed Advisors LLCDirector	Buy (Open-market buy)	1.33M sh	$20M						—
Sep 21, 2026	Insider	Gordon Carl LDirector	Buy (Open-market buy)	1.33M sh	$20M						—

1W / 1M / 6M = how ETRA moved from the trade or filing date.

Insider trading in ETRA: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Orbimed Advisors LLC	Director	1	+$20M		Sep 21, 2026
Gordon Carl L	Director	1	+$20M		Sep 21, 2026

Frequently asked questions

Are ETRA insiders buying or selling?

Over the last 12 months 2 insiders made 2 open-market purchases worth $40M and 0 insiders made 0 open-market sales worth $0, a net +$40M.

What is the latest insider trade in ETRA?

Orbimed Advisors LLC, Director filed a buy (open-market buy) of 1.33M sh worth $20M on Sep 21, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.